Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05987163
NA

Study to Evaluate the Safety and Effectiveness of GP0116

Sponsor: Galderma R&D

View on ClinicalTrials.gov

Summary

This is a prospective, randomized, evaluator-blinded, comparator-controlled, parallel group, multicenter study in the U.S. for correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds (NLFs).

Official title: A Randomized, Evaluator-blinded, Parallel Group, Comparator-controlled, Multicenter Study to Evaluate the Safety and Effectiveness of GP0116 for Correction of Moderate to Severe Dynamic Facial Wrinkles and Folds, Such as Nasolabial Folds.

Key Details

Gender

All

Age Range

22 Years - Any

Study Type

INTERVENTIONAL

Enrollment

186

Start Date

2023-04-12

Completion Date

2026-03-31

Last Updated

2025-07-02

Healthy Volunteers

No

Interventions

DEVICE

GP0116

GP0116 is an injectable, sterile, transparent product.

DEVICE

Active Comparator: FDA approved dermal filler device (RHA 3)

FDA approved dermal filler device (RHA 3)

Locations (19)

Galderma Investigational Site (Site#8074)

Santa Monica, California, United States

Galderma Investigational Site (Site#8478)

Vista, California, United States

Galderma Investigational Site (Site#8680)

Westport, Connecticut, United States

Galderma Investigational Site (Site#8479)

Bradenton, Florida, United States

Galderma Investigational Site (Site#7030)

Coral Gables, Florida, United States

Galderma Investigational Site (Site#8284)

Coral Gables, Florida, United States

Galderma Investigational Site (Site#8126)

West Palm Beach, Florida, United States

Galderma Investigational Site (Site#7042)

Atlanta, Georgia, United States

Galderma Investigational Site (Site#8580)

New Orleans, Louisiana, United States

Galderma Investigational Site (Site#8481)

Chestnut Hill, Massachusetts, United States

Galderma Investigational Site (Site#8631)

Birmingham, Michigan, United States

Galderma Investigational Site (Site#8658)

New York, New York, United States

Galderma Investigational Site (Site#8482)

Chapel Hill, North Carolina, United States

Galderma Investigational Site (Site#8648)

Wilmington, North Carolina, United States

Galderma Investigational Site (Site#8783)

Cincinnati, Ohio, United States

Galderma Investigational Site (Site#8496)

Nashville, Tennessee, United States

Galderma Investigational Site (Site#8662)

Spring, Texas, United States

Galderma Investigational Site (Site#7047)

Arlington, Virginia, United States

Galderma Investigational Site (Site#8784)

San Juan, Puerto Rico